One of the out-patient rehab alternatives for people in Caribou struggling with opioid abuse and addiction is opioid maintenance therapy. Licensed facilities and doctors are certified to dispense certain medications to opioid addicted clients, many that are opioids themselves and are addictive. With low enough amounts the client does not experience high feelings but also doesn't have acute cravings and isn't experiencing opioid withdrawal. Methadone is the first medication used for this reason, but there are alternative options currently to select from.
Methadone is an opiate and can be taken at an outpatient medical center licensed to dispense the drug, which is taken daily in liquid or pill form. The price of the drug is around $150 a month. Buprenorphine is also an opioid-based med, and is in pill form often taken one day on, one day off. But unlike Methadone which can only be given in structured clinics, Buprenorphine can be prescribed and administered in doctor's offices. The cost monthly of buprenorphine is approximately $300.00 a month for the generic of the medication. There is also a version of buprenorphine that contains the ingredient naloxone, which is a drug which reverses the effects of opioids. Someone consuming this version of the drug, AKA Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It is also taken every day, and costs about $450 /month. Naltrexone is an additional med taken in opioid maintenance therapy, but unlike the other medications aforementioned it's an opioid blocker and isn't an opiate. A person has the choice to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, it prevents a person from experience high feelings from opioids, and in turn lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 monthly.
There are 1 Drug and Alcohol Rehabilitation Facilities offering this service in Caribou, ME
For All Drug and Alcohol Treatment Facilities In Caribou, Click Here.